The Medicines Company Reports First-Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Medicines Co. (MDCO) Misses Q1 EPS by 20c
April 26, 2017 7:17 AM EDTMedicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($1.44), $0.20 worse than the analyst estimate of ($1.24). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $34.08 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
... More